Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.0bn reported value +22.5% vs Q3 2022
60positions
67.0%in top 10
14 new 23 added 17 reduced 14 sold out vs Q3 2022

Options: 8 call positions ($108.7m notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q4 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 GSK PLC SPONSORED ADR GSK GSK 3,490,457 $123.8m11.98% 11.98% AddedShares held: Q3 2022 2.9m, Q4 2022 3.5m +551.4k +551,387 18.8%
2 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 1,064,446 $121.1m11.72% 11.72% ReducedShares held: Q3 2022 1.3m, Q4 2022 1.1m -205.1k -205,145 -16.2%
3 NATERA INC COM NTRA NTRA 2,685,959 $107.9m10.44% 10.44% AddedShares held: Q3 2022 1.4m, Q4 2022 2.7m +1.3m +1,260,357 88.4%
4 SANOFI SPONSORED ADR SNY SNY 1,603,348 $77.7m7.52% 7.52% AddedShares held: Q3 2022 996.0k, Q4 2022 1.6m +607.3k +607,313 61.0%
5 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 232,787 $64.7m6.27% 6.27% ReducedShares held: Q3 2022 255.2k, Q4 2022 232.8k -22.4k -22,439 -8.8%
6 DANAHER CORPORATION COM DHR DHR 162,571 $43.2m4.18% 4.18% AddedShares held: Q3 2022 162.5k, Q4 2022 162.6k +25 +25 0.0%
7 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 4,712,597 $43.0m4.16% 4.16% AddedShares held: Q3 2022 4.1m, Q4 2022 4.7m +649.7k +649,662 16.0%
8 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 1,620,713 $41.2m3.99% 3.99% AddedShares held: Q3 2022 1.2m, Q4 2022 1.6m +409.3k +409,279 33.8%
9 BIOGEN INC COM BIIB BIIB 137,348 $38.0m3.68% 3.68% AddedShares held: Q3 2022 60.1k, Q4 2022 137.3k +77.2k +77,204 128.4%
10 CATALENT INC COM CTLT CTLT 691,677 $31.1m3.01% 3.01% NewShares held: Q3 2022 0, Q4 2022 691.7k
11 ILLUMINA INC COM ILMN ILMN 140,067 $28.3m2.74% 2.74% AddedShares held: Q3 2022 107.0k, Q4 2022 140.1k +33.1k +33,065 30.9%
12 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 558,774 $24.9m2.41% 2.41% ReducedShares held: Q3 2022 626.4k, Q4 2022 558.8k -67.6k -67,598 -10.8%
13 ENVISTA HOLDINGS CORPORATION COM NVST NVST 642,405 $21.6m2.09% 2.09% AddedShares held: Q3 2022 633.0k, Q4 2022 642.4k +9.4k +9,404 1.5%
14 SPDR SER TR S&P BIOTECH XBI XBI 216,087 $17.9m1.74% 1.74% AddedShares held: Q3 2022 100.0k, Q4 2022 216.1k +116.1k +116,087 116.1%
15 CENTENE CORP DEL COM CNC CNC 214,561 $17.6m1.70% 1.70% AddedShares held: Q3 2022 191.3k, Q4 2022 214.6k +23.3k +23,253 12.2%
16 HALEON PLC SPON ADS HLN HLN 1,881,470 $15.1m1.46% 1.46% NewShares held: Q3 2022 0, Q4 2022 1.9m
17 ICON PLC SHS ICLR ICLR 66,693 $13.0m1.25% 1.25% AddedShares held: Q3 2022 10.2k, Q4 2022 66.7k +56.5k +56,481 553.1%
18 AVANTOR INC COM AVTR AVTR 600,200 $12.7m1.23% 1.23% AddedShares held: Q3 2022 74.5k, Q4 2022 600.2k +525.7k +525,748 706.2%
19 TENET HEALTHCARE CORP COM NEW THC THC 254,586 $12.4m1.20% 1.20% NewShares held: Q3 2022 0, Q4 2022 254.6k
20 SERES THERAPEUTICS INC COM COM 2,200,999 $12.3m1.19% 1.19% AddedShares held: Q3 2022 1.9m, Q4 2022 2.2m +265.2k +265,174 13.7%
21 XENON PHARMACEUTICALS INC COM XENE XENE 275,704 $10.9m1.05% 1.05% AddedShares held: Q3 2022 259.6k, Q4 2022 275.7k +16.1k +16,092 6.2%
22 HUMANA INC COM HUM HUM 20,911 $10.7m1.04% 1.04% ReducedShares held: Q3 2022 24.6k, Q4 2022 20.9k -3.7k -3,661 -14.9%
23 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 880,487 $10.1m0.98% 0.98% NewShares held: Q3 2022 0, Q4 2022 880.5k
24 REPLIGEN CORP COM RGEN RGEN 57,004 $9.7m0.93% 0.93% AddedShares held: Q3 2022 3.6k, Q4 2022 57.0k +53.4k +53,363 1465.6%
25 IONIS PHARMACEUTICALS INC COM IONS IONS 240,975 $9.1m0.88% 0.88% AddedShares held: Q3 2022 201.8k, Q4 2022 241.0k +39.1k +39,142 19.4%
26 MODEL N INC COM MODN MODN 217,880 $8.8m0.86% 0.86% NewShares held: Q3 2022 0, Q4 2022 217.9k
27 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 2,001,994 $8.6m0.84% 0.84% ReducedShares held: Q3 2022 8.8m, Q4 2022 2.0m -6.8m -6,839,610 -77.4%
28 VAXCYTE INC COM PCVX PCVX 178,453 $8.6m0.83% 0.83% NewShares held: Q3 2022 0, Q4 2022 178.5k
29 LIQUIDIA CORPORATION COM NEW LQDA LQDA 1,290,913 $8.2m0.80% 0.80% ReducedShares held: Q3 2022 1.4m, Q4 2022 1.3m -110.5k -110,530 -7.9%
30 APELLIS PHARMACEUTICALS INC COM APLS APLS 154,796 $8.0m0.77% 0.77% NewShares held: Q3 2022 0, Q4 2022 154.8k
31 VERA THERAPEUTICS INC CL A VERA VERA 411,308 $8.0m0.77% 0.77% AddedShares held: Q3 2022 156.1k, Q4 2022 411.3k +255.2k +255,179 163.4%
32 IVERIC BIO INC COM OPHT OPHT 350,747 $7.5m0.73% 0.73% NewShares held: Q3 2022 0, Q4 2022 350.7k
33 TARO PHARMACEUTICAL INDS LTD SHS TARO TARO 225,462 $6.5m0.63% 0.63% AddedShares held: Q3 2022 223.4k, Q4 2022 225.5k +2.1k +2,079 0.9%
34 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 1,507,663 $6.4m0.62% 0.62% AddedShares held: Q3 2022 1.5m, Q4 2022 1.5m +2.0k +1,958 0.1%
35 EVOLUS INC COM EOLS EOLS 713,774 $5.4m0.52% 0.52% NewShares held: Q3 2022 0, Q4 2022 713.8k
36 INCYTE CORP COM INCY INCY 63,996 $5.1m0.50% 0.50% NewShares held: Q3 2022 0, Q4 2022 64.0k
37 GUARDANT HEALTH INC COM GH GH 146,129 $4.0m0.38% 0.38% ReducedShares held: Q3 2022 171.5k, Q4 2022 146.1k -25.4k -25,352 -14.8%
38 MERUS N V COM MRUS MRUS 184,556 $2.9m0.28% 0.28% ReducedShares held: Q3 2022 276.7k, Q4 2022 184.6k -92.1k -92,117 -33.3%
39 AEROVATE THERAPEUTICS INC COM COM 91,252 $2.7m0.26% 0.26% NewShares held: Q3 2022 0, Q4 2022 91.3k
40 PLIANT THERAPEUTICS INC COM PLRX PLRX 137,423 $2.7m0.26% 0.26% ReducedShares held: Q3 2022 294.1k, Q4 2022 137.4k -156.7k -156,680 -53.3%
41 CABALETTA BIO INC COM CABA CABA 282,874 $2.6m0.25% 0.25% ReducedShares held: Q3 2022 560.5k, Q4 2022 282.9k -277.6k -277,592 -49.5%
42 BIOHAVEN LTD COM BHVN BHVN 185,595 $2.6m0.25% 0.25% NewShares held: Q3 2022 0, Q4 2022 185.6k
43 IQVIA HLDGS INC COM IQV IQV 10,889 $2.2m0.22% 0.22% AddedShares held: Q3 2022 8.3k, Q4 2022 10.9k +2.6k +2,592 31.2%
44 AGILENT TECHNOLOGIES INC COM A A 11,878 $1.8m0.17% 0.17% ReducedShares held: Q3 2022 21.5k, Q4 2022 11.9k -9.6k -9,643 -44.8%
45 AMNEAL PHARMACEUTICALS INC COM STK CL A AMRX AMRX 830,960 $1.7m0.16% 0.16% ReducedShares held: Q3 2022 4.7m, Q4 2022 831.0k -3.9m -3,859,852 -82.3%
46 XOMA ROYALTY CORPORATION COM NEW XOMA XOMA 86,873 $1.6m0.15% 0.15% ReducedShares held: Q3 2022 88.4k, Q4 2022 86.9k -1.5k -1,529 -1.7%
47 REVVITY INC COM RVTY RVTY 11,178 $1.6m0.15% 0.15% AddedShares held: Q3 2022 10.9k, Q4 2022 11.2k +248 +248 2.3%
48 BIO-TECHNE CORP COM TECH TECH 16,635 $1.4m0.13% 0.13% NewShares held: Q3 2022 0, Q4 2022 16.6k
49 ARGENX SE SPONSORED ADR ARGX ARGX 3,476 $1.3m0.13% 0.13% ReducedShares held: Q3 2022 3.5k, Q4 2022 3.5k -26 -26 -0.7%
50 AADI BIOSCIENCE INC COM WHWK WHWK 101,918 $1.3m0.13% 0.13% UnchangedShares held: Q3 2022 101.9k, Q4 2022 101.9k
51 HESKA CORP COM RESTRC NEW HSKA HSKA 19,475 $1.2m0.12% 0.12% AddedShares held: Q3 2022 6.9k, Q4 2022 19.5k +12.5k +12,532 180.5%
52 GOHEALTH INC CL A NEW CL A NEW 50,522 $528.0k0.05% 0.05% NewShares held: Q3 2022 0, Q4 2022 50.5k
53 FATE THERAPEUTICS INC COM FATE FATE 43,562 $439.5k0.04% 0.04% ReducedShares held: Q3 2022 141.6k, Q4 2022 43.6k -98.0k -97,996 -69.2%
54 AFFIMED N V COM COM 330,224 $409.5k0.04% 0.04% ReducedShares held: Q3 2022 1.9m, Q4 2022 330.2k -1.6m -1,557,775 -82.5%
55 GOSSAMER BIO INC COM GOSS GOSS 154,212 $334.6k0.03% 0.03% ReducedShares held: Q3 2022 548.4k, Q4 2022 154.2k -394.2k -394,219 -71.9%
56 GLYCOMIMETICS INC COM COM 100,579 $304.8k0.03% 0.03% UnchangedShares held: Q3 2022 100.6k, Q4 2022 100.6k
57 AC IMMUNE SA SHS ACIU ACIU 124,589 $254.2k0.02% 0.02% UnchangedShares held: Q3 2022 124.6k, Q4 2022 124.6k
58 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 67,743 $154.5k0.01% 0.01% UnchangedShares held: Q3 2022 67.7k, Q4 2022 67.7k
59 SONIDA SENIOR LIVING INC COM SNDA SNDA 11,791 $147.4k0.01% 0.01% UnchangedShares held: Q3 2022 11.8k, Q4 2022 11.8k
60 BOLT BIOTHERAPEUTICS INC COM COM 31,172 $40.5k0.00% 0.00% UnchangedShares held: Q3 2022 31.2k, Q4 2022 31.2k

Sold out since Q3 2022

SecurityTickerShares held beforeValue then
BIOHAVEN PHARMACTL HLDG CO L BHVN BHVN 637,139 $96.3m637.1k shares
ELEVANCE HEALTH INC ELV ELV 33,040 $15.0m33.0k shares
LANTHEUS HLDGS INC LNTH LNTH 206,893 $14.6m206.9k shares
AMARIN CORP PLC 11,962,744 $13.0m12.0m shares
ABIOMED INC ABMD ABMD 52,970 $13.0m53.0k shares
VIRIDIAN THERAPEUTICS INC VRDN VRDN 478,387 $9.8m478.4k shares
MARAVAI LIFESCIENCES HLDGS I MRVI MRVI 160,000 $4.1m160.0k shares
AERIE PHARMACEUTICALS INC AERI AERI 256,289 $3.9m256.3k shares
POINT BIOPHARMA GLOBAL INC 410,052 $3.2m410.1k shares
908 DEVICES INC MASS MASS 130,768 $2.2m130.8k shares
INTUITIVE SURGICAL INC ISRG ISRG 9,125 $1.7m9.1k shares
LABORATORY CORP AMER HLDGS 7,233 $1.5m7.2k shares
MILESTONE PHARMACEUTICALS IN MIST MIST 126,826 $1.2m126.8k shares
THIRD HARMONIC BIO INC 10,000 $189.7k10.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
GSK PLC GSK · Call GSKCall 2,093,700 $73.6m2.1m shares Unchanged
ELEVANCE HEALTH INC ELV · Call ELVCall 28,042 $14.4m28.0k shares New
SPDR SER TR XBI · Call XBICall 90,000 $7.5m90.0k shares Unchanged
MERCK & CO INC MRK · Call MRKCall 48,700 $5.4m48.7k shares Unchanged
AMARIN CORP PLC Call Call 3,284,114 $4.0m3.3m shares New
TEVA PHARMACEUTICAL INDS LTD Call Call 272,900 $2.5m272.9k shares Unchanged
COMMUNITY HEALTH SYS INC NEW CYH · Call CYHCall 312,900 $1.4m312.9k shares Unchanged
CATALENT INC CTLT · Call CTLTCall 2,000 $90.0k2.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17